Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 12, 2001

View Archived Issues

KS Biomedix Drops Development Of Lead Osteoarthritis Compound

EU Agrees To $1B In Support Of Genome, Biotech Research

Surprise Discovery Shows Cytokines Can Help Repair DNA

Teva Invests $10M In Proneuron, Buys Into Expanded Use Of COP-1

Genome Express Raises $11M To Advance Work In Genomics

Abingworth Management Closes Life Science Fund At US$225M

Phytopharm Gets Good Results In Phase II Obesity Study Of P57

Medigene Seeks First Approval, Files Application For Leuprogel

Cytos, Millennium Enter Orphan Target Discovery Collaboration

Other News To Note

Swedish Research Council Backs Therapeutic Cloning

ExonHit, BioMirieux-Pierre Fabre Form Cancer Research Alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...